Form 4: Quest Diagnostics CFO Acquires Shares Through Dividend Reinvestment Plan

Quest Diagnostics Executive Vice President and CFO Sam Samad acquired 72 shares of common stock through a dividend reinvestment plan, increasing his direct beneficial ownership to 25,673 shares.

Summary

• Sam Samad, Executive Vice President and CFO of Quest Diagnostics Inc. (DGX), acquired 72 shares of common stock on July 21, 2025.
• The acquisition occurred at a price of $167.496 per share.
• These shares were acquired pursuant to a dividend reinvestment plan administered by his broker.
• Following this transaction, Samad directly beneficially owns 25,673 shares of Quest Diagnostics common stock.
• The transaction was reported early on Form 4, though it was eligible for deferred reporting on Form 5 under Rule 16a-6.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even through a dividend reinvestment plan, generally indicates continued confidence in the company's performance and future prospects.

Positives

• The acquisition of shares by a key executive, even through a dividend reinvestment plan, generally indicates continued confidence in the company's performance and future prospects.
• The CFO is increasing his direct stake in the company, aligning his interests with those of shareholders.

Future Outlook

N/A

Industry Context

This filing details a routine insider transaction for Quest Diagnostics, a leading clinical laboratory company. Such transactions are common and do not typically reflect broader industry trends, but rather individual executive investment decisions.

Comparison to Industry Standards

• This is a standard Form 4 filing for an insider transaction, common across all publicly traded companies.
• The acquisition via a dividend reinvestment plan is a routine method for executives to increase their holdings, aligning with common practices for executive share ownership.

Stakeholder Impact

• Shareholders: May view the insider acquisition as a positive signal of management confidence and alignment of interests.

Key Dates

Recommendation

The filing reports a routine acquisition of shares by a key executive through a dividend reinvestment plan. While it signals continued confidence from management, the transaction size is small and part of a regular program, thus not warranting a change in investment thesis for most investors. It reinforces a 'hold' position for existing shareholders.

Keywords

Quest Diagnostics, DGX, Sam Samad, insider trading, Form 4, dividend reinvestment plan, common stock, beneficial ownership, executive compensation